Chongqing Emergency Medical Center
10
5
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Magnetocardiography in the Accurate Identification of Myocardial Infarction
Role: collaborator
MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients
Role: collaborator
MCG for Risk Stratifications of Patients With Chest Pain
Role: collaborator
Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis
Role: collaborator
Diagnosis of Myocardial Ischemia With MCG Using SPECT as a Reference Standard
Role: collaborator
Determination of MCG Reference Intervals in Healthy Individuals
Role: collaborator
Baseline Investigation of Patients With Cardiac Arrest in China
Role: collaborator
Effects of Contrast Media Temperature on Image Quality and Clinical Adverse Events in Coronary CTA
Role: lead
Prediction Study of Complications After Severe Trauma
Role: collaborator
Randomized Controlled Trial of Long-term Mild Hypothermia for Severe Traumatic Brain Injury
Role: collaborator
All 10 trials loaded